Blog
RSS FeedPosted by Michael Wonder on 19 Mar 2019
Think drugs are expensive in the U.S.? Just try China
19 March 2019 - Beijing will want pharma companies to share the pain of the country’s growing health care costs. ...
Posted by Michael Wonder on 06 Mar 2019
China moves to expand cancer medicine access
6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality ...
Posted by Michael Wonder on 27 Feb 2019
China approves first biosimilar of foreign drug, breaking Roche monopoly
27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...
Posted by Michael Wonder on 19 Feb 2019
China to establish collaboration network for rare disease diagnosis, treatment
18 February 2019 - China will establish a national collaborative network of hospitals for rare disease diagnosis and treatment to ...
Posted by Michael Wonder on 13 Feb 2019
China pushes forward reforms to expand access to anti-cancer drugs
13 February 2019 - Life-saving anti-cancer drugs, once hard to afford or find on the market by many patients in ...
Posted by Michael Wonder on 29 Jan 2019
Pfizer launches China's first pay for performance model for cancer
26 January 2019 - Pfizer launched a pay-for-performance insurance program for its breast cancer drug Ibrance palbociclib in China. The ...
Posted by Michael Wonder on 21 Jan 2019
China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs
19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...
Posted by Michael Wonder on 18 Jan 2019
China unveils pilot "group-buying" plan to cut drug prices
17 January 2019 - China has unveiled a pilot medicine procurement program to be tried in 11 major cities to ...
Posted by Michael Wonder on 13 Jan 2019
China has a very unhealthy interest in our medical data
14 January 2019 - Chinese companies are required by law to obey directives from Beijing's intelligence agencies. So why would ...
Posted by Michael Wonder on 07 Jan 2019
Pharma firms face shake-up with China’s plan to bulk-buy drugs
2 January 2019 - Pilot programme involves major cities clubbing together to purchase certain medicines, driving down prices. ...
Posted by Michael Wonder on 19 Dec 2018
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis
18 December 2018 - China is the first country to approve roxadustat. ...
Posted by Michael Wonder on 17 Dec 2018
‘Painful’ consolidation ahead for China’s generic drug makers, as Beijing gets behind procurement revamp
17 December 2018 - 52% difference in price on average between winning bids under centralised bulk drugs procurement pilot and last ...
Posted by Michael Wonder on 10 Dec 2018
China drug prices were cut more than expected, Credit Suisse says
10 December 2018 - Serena Shao, head of China healthcare research at Credit Suisse, talks about Chin's health care stocks. ...
Posted by Michael Wonder on 09 Dec 2018
Chinese vice premier calls for centralised medicine procurement to cut prices
7 December 2018 - Chinese Vice Premier Sun Chunlan on Friday stressed the need for centralized medicine procurement and market-oriented ...
Posted by Michael Wonder on 06 Dec 2018
China's drug makers plunge most since 2009 on price concerns
6 December 2018 - Price of one drug was cut by 90% in official tender: report. ...